Add time:08/17/2019         Source:sciencedirect.com

Treatment of diastereomeric (1R,5R,6R)- and (1R,5R,6S)-6-hydroxymethyl-2,6-dimethyl-7-oxabicyclo[3.2.1]oct-2-enes with Et3SiOTf leads to scalemic (1R,5R,6R)- and (1R,5R,6S)-6-hydroxy-2,6-dimethyl-8-oxabicyclo[3.3.1]non-2-enes.

We also recommend Trading Suppliers and Manufacturers of 2(1H)-Pyridinethione,3-(triethylsilyl)-(9CI) (cas 116725-50-9). Pls Click Website Link as below: cas 116725-50-9 suppliers